Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Goobit Group | BTCX | 22. nov 2024 | 0.14 | -2.05 |
Goodbye Kansas Group | GBK | 22. nov 2024 | 1.39 | +0.72 |
Gosol Energy Group AB | GOSOL | 22. nov 2024 | 1.15 | -2.37 |
Greater Than | GREAT | 22. nov 2024 | 28.90 | -7.37 |
Green Landscaping Group | GREEN | 22. nov 2024 | 69.90 | -2.24 |
Greenmerc | GMERCB | 22. nov 2024 | 6.56 | -9.89 |
Gruvaktiebolaget Viscaria | VISC | 22. nov 2024 | 22.10 | +1.61 |
Gränges | GRNG | 22. nov 2024 | 117.80 | -0.51 |
Grängesberg Exploration Holding | GRANGX | 22. nov 2024 | 9.00 | +2.62 |
Guard Therapeutics International | GUARD | 22. nov 2024 | 20.60 | +1.98 |
Guideline Geo | GGEO | 22. nov 2024 | 7.94 | +1.28 |
Gullberg & Jansson | GJAB | 22. nov 2024 | 15.35 | +0.33 |
H&D Wireless Sweden Holding B | HDWB | 22. nov 2024 | 0.00 | 0.00 |
H&M B | HMB | 22. nov 2024 | 155.40 | +1.20 |
HAKI Safety A | HAKIA | 22. nov 2024 | 27.00 | 0.00 |
HAKI Safety B | HAKIB | 22. nov 2024 | 25.40 | 0.00 |
Hamlet BioPharma AB (publ) | HAMLETB | 22. nov 2024 | 2.62 | -2.24 |
Hansa Biopharma | HNSA | 22. nov 2024 | 30.68 | +2.68 |
Hanza AB | HANZA | 22. nov 2024 | 68.05 | +3.81 |
Harm Reduction Group | NOHARM | 22. nov 2024 | 0.05 | +0.38 |
Havsfrun Investment | HAVS | 22. nov 2024 | 13.70 | +4.58 |
Havsfrun Investment B | HAVB | 22. nov 2024 | 13.70 | +4.58 |
Haypp Group | HAYPP | 22. nov 2024 | 61.20 | +2.34 |
Headsent | VIMAB | 22. nov 2024 | 7.50 | -3.23 |
Heba B | HEBAB | 22. nov 2024 | 31.30 | +2.29 |
Hedera Group | HEGR | 22. nov 2024 | 2.42 | -3.20 |
Heimstaden Pref | HEIMPREF | 22. nov 2024 | 14.04 | -2.90 |
Heliospectra | HELIO | 22. nov 2024 | 0.49 | -1.01 |
Hemnet Group | HEM | 22. nov 2024 | 325.80 | +1.50 |
Hemply Balance | HMPLY | 22. nov 2024 | 0.04 | +11.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.